NASDAQ 100

US stocks ride out euro temblors

US stock markets posted solid gains in a seesaw week of trade that was dominated by Facebook's post-IPO slump and heightened fears of a Greek euro exit and Spanish banking crisis.

Banks sink as US stocks close mixed

Falling banking stocks dragged the US equity market down on Thursday amid worry about fallout from a Greek default, but Apple and Google helped the Nasdaq gain for a fourth straight day. The Dow Jones Industrial Average fell 40.72 points (0.35 per cent) to finish at 11,478.13.

Wall Street: stocks low amid Korea woes

US stocks closed sharply down on Tuesday as escalating tensions between North and South Korea and new uneasiness over the eurozone fuelled fears about the global economy.

US investors welcome health bill

European shares closed flat on Monday, with banks paring some earlier losses as worries over Greece eased, while drugmakers largely gained after the United States passed a healthcare bill which provided clarity for the sector.

Wall Street surges after Fed rate cut

US stocks soared on Tuesday as investors cheered the Federal Reserve decision to cut its key rate to near zero and its pledge of more steps to revive economic activity.

Market surges at open on Wall St rally

The Australian market has shot up over 3.5 per cent at open today, boosted by a near 11 per cent surge on Wall Street overnight ahead of an expected interest rate cut.

Investors wipe $56bn from local market

The Australian stock market has clocked up its second-worst trading day for the year, closing down 5 per cent to its lowest point in three-years as panic selling engulfs markets around the world due to growing fears about the global financial crisis.

Market in freefall on failed US bailout

Australian stocks suffered at the opening of trading on the Australian Securities Exchange, after the US House of Representatives rejected the $US700 billion rescue package.

Shares dive, caps off weakest start to year in 17 years

The Australian stock market failed to follow Wall Street's higher lead overnight, with the benchmark index falling below the 6,000 mark, leaving investors nursing the weakest start to new year trading for 17 years.

PharmAust seals US deal

Nedlands-based pharmaceutical company PharmAust Ltd will take a 39.5 per cent stake in Nasdaq-listed US-based Commonwealth Biotechnologies Inc in exchange for its discovery chemistry subsidiary, Mimotopes Pty Ltd.

PharmAust sells Mimotopes, takes stake in C'wealth Biotech

Nedlands-based pharmaceutical company PharmAust Ltd will take a 39.5 per cent stake in NASDAQ-listed US-based Commonwealth Biotechnologies Inc in exchange for its its discovery chemistry subsidiary Mimotopes Pty Ltd.

PharmAust sells Mimotopes for up to $10.6m

WA pharmaceutical company PharmAust Ltd will sell discovery chemistry subsidiary Mimotopes Pty Ltd to US-based Commonwealth Biotechnologies Inc for a scrip consideration of between $8.6 and $10.6 million, 16 months after PharmAust acquired the company.

Pages

Corporate Finance

Corporate Finance

ECM driven by Business News' corporate finance database includes private equity relationships

Mergers and Aquisitions

Mergers & Acquisitions

Who are the leading hands in the West Australian M&A marketplace

Exporters

LabelValue
Rio Tinto$26.13bn
BHP Billiton Iron Ore$20.48bn
North West Shelf Venture$14.92bn
Gold Corporation$6.82bn
Fortescue Metals Group$6.68bn
Others$22.08bn
FMG
CF 2011
CF Q3 FY12

Feedback Form